Rhadbdomyolysis after coronary artery bypass grafting in a patient receiving simvastatin

Journal of Thoracic and Cardiovascular Surgery

Volumn 116, Issue 4, 1998, Pages 654-655

  Alvarez, J M ^a   Rawdanowiz, T J ^a   Goldstein, J ^a  

^a MONASH MEDICAL CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ATENOLOL; CARDIPRIN; CEFTRIAXONE; CREATINE KINASE; DOPAMINE; FENTANYL; FLUINDOSTATIN; FUROSEMIDE; MANNITOL; NORADRENALIN; NOTEN; PANCURONIUM BROMIDE; PROPOFOL; SIMVASTATIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; CASE REPORT; CORONARY ARTERY BYPASS GRAFT; CORONARY RISK; HEMODIALYSIS; HUMAN; HYPERLIPIDEMIA; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FAILURE; MALE; MYALGIA; PRIORITY JOURNAL; RHABDOMYOLYSIS;

EID: 0031688505     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5223(98)70177-1     Document Type: Article

References (5)

1. JF Walker World wide experience with simvastatin/lovastatin Eur Heart J 13 suppl B 1992 21 22
2. L Campeau G Knatterud B Hunninghake N Domanski Optimising cholesterol lowering therapy: contribution of the post coronary artery bypass graft trial Eur Heart J 18 1997 1683 1685
3. WR Garnett Interactions with hydroxy methylglutaryl coenzyme A reductase inhibitors Am J Health Syst Pharm 52 1995 1639 1644
4. AD Kogan S Orenstein Lovastatin induced acute rhabdomyolysis Postgrad Med J 66 1996 294 296
5. AD Rosenberg MJ Neuwirth LJ Kagen K Singh HD Fischer RL Bernstein Intraoperative rhabdomyolysis in a patient receiving Pravostatin, a hydroxy-III-methylglutaryl co-enzyme A (HMG coA) reductase inhibitor Anaesth Analg 81 1995 1089 1091